Biotech Cara Therapeutics closed up 7% after popping as much as 14% percent during…
Tag:
Trial
-
-
Investors are not reacting favorably to the Seattle Genetics’ stage three trial results for…
-
Celgene plunges following the drugmaker’s announcement late Thursday that it would halt phase 3…